Bruker Corporation (NASDAQ:BRKR) will speak at the JP Morgan Healthcare Conference on Wednesday, January 13. The conference call will take place at the Westin St. Francis Hotel in San Francisco. Speaking will be Bruker President and Chief Executive Officer Frank Laukien. Interested parties are invited to listen to a webcast of the presentation on the company’s Investor website, http://ir.bruker.com/. The webcast will remain on the site as a replay for thirty days after the end of the event.
Top Best Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move. Sign up for our Free Stock Newsletter.
Bruker Corporation designs, manufactures, markets and services life science and materials research systems and associated products to address the needs of its customers in life science research and pharmaceutical, biotechnology and molecular diagnostics research, as well as in materials and chemical analysis in various industries and government applications. Its core technology platforms include X-ray technologies, magnetic resonance technologies, mass spectrometry technologies, optical emission spectroscopy and infrared and Raman molecular spectroscopy technologies. It also manufactures and distributes a range of field analytical systems for chemical, biological, radiological and nuclear (CBRN), detection, as well as superconducting wire products and devices. It operates in four divisions: Bruker AXS, Bruker Daltonics, Bruker Optics and Bruker BioSpin.
Sign up for Top Best Penny Stocks' free newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
Follow us on Twitter: http://www.Twitter.com/topbestps
About Us
Top Best Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer.
